<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34578365</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Rhinovirus Inhibitors: Including a New Target, the Viral RNA.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1784</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13091784</ELocationID><Abstract><AbstractText>Rhinoviruses (RVs) are the main cause of recurrent infections with rather mild symptoms characteristic of the common cold. Nevertheless, RVs give rise to enormous numbers of absences from work and school and may become life-threatening in particular settings. Vaccination is jeopardised by the large number of serotypes eliciting only poorly cross-neutralising antibodies. Conversely, antivirals developed over the years failed FDA approval because of a low efficacy and/or side effects. RV species A, B, and C are now included in the fifteen species of the genus <i>Enteroviruses</i> based upon the high similarity of their genome sequences. As a result of their comparably low pathogenicity, RVs have become a handy model for other, more dangerous members of this genus, e.g., poliovirus and enterovirus 71. We provide a short overview of viral proteins that are considered potential drug targets and their corresponding drug candidates. We briefly mention more recently identified cellular enzymes whose inhibition impacts on RVs and comment novel approaches to interfere with infection via aggregation, virus trapping, or preventing viral access to the cell receptor. Finally, we devote a large part of this article to adding the viral RNA genome to the list of potential drug targets by dwelling on its structure, folding, and the still debated way of its exit from the capsid. Finally, we discuss the recent finding that G-quadruplex stabilising compounds impact on RNA egress possibly via obfuscating the unravelling of stable secondary structural elements.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Real-Hohn</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0334-2877</Identifier><AffiliationInfo><Affiliation>Center for Medical Biochemistry, Vienna Biocenter, Max Perutz Laboratories, Medical University of Vienna, Dr. Bohr Gasse 9/3, A-1030 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaas</LastName><ForeName>Dieter</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9612-3376</Identifier><AffiliationInfo><Affiliation>Center for Medical Biochemistry, Vienna Biocenter, Max Perutz Laboratories, Medical University of Vienna, Dr. Bohr Gasse 9/3, A-1030 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P 31392</GrantID><Acronym>FWF_</Acronym><Agency>Austrian Science Fund FWF</Agency><Country>Austria</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000634">Aminoquinolines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010848">Picolinic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C567962">pyridostatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000634" MajorTopicYN="N">Aminoquinolines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010848" MajorTopicYN="N">Picolinic Acids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">G-quadruplex</Keyword><Keyword MajorTopicYN="N">anti-viral</Keyword><Keyword MajorTopicYN="N">drug candidate</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">inhibition</Keyword><Keyword MajorTopicYN="N">picornavirus</Keyword><Keyword MajorTopicYN="N">pyridostatin</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword><Keyword MajorTopicYN="N">uncoating</Keyword><Keyword MajorTopicYN="N">viral RNA structure</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34578365</ArticleId><ArticleId IdType="pmc">PMC8473194</ArticleId><ArticleId IdType="doi">10.3390/v13091784</ArticleId><ArticleId IdType="pii">v13091784</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Palmenberg A.C., Gern J.E. Classification and evolution of human rhinoviruses. Methods Mol. Biol. 2015;1221:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441521</ArticleId><ArticleId IdType="pubmed">25261302</ArticleId></ArticleIdList></Reference><Reference><Citation>Stott E.J., Killington R.A. Rhinoviruses. Annu. Rev. Microbiol. 1972;26:503&#x2013;524. doi: 10.1146/annurev.mi.26.100172.002443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.mi.26.100172.002443</ArticleId><ArticleId IdType="pubmed">4343002</ArticleId></ArticleIdList></Reference><Reference><Citation>Gern J.E., Mosser A.G., Swenson C.A., Rennie P.J., England R.J., Shaffer J., Mizoguchi H. Inhibition of rhinovirus replication in vitro and in vivo by acid-buffered saline. J. Infect. Dis. 2007;195:1137&#x2013;1143. doi: 10.1086/512858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/512858</ArticleId><ArticleId IdType="pmc">PMC7110134</ArticleId><ArticleId IdType="pubmed">17357049</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs S.E., Lamson D.M., St George K., Walsh T.J. Human rhinoviruses. Clin. Microbiol. Rev. 2013;26:135&#x2013;162. doi: 10.1128/CMR.00077-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00077-12</ArticleId><ArticleId IdType="pmc">PMC3553670</ArticleId><ArticleId IdType="pubmed">23297263</ArticleId></ArticleIdList></Reference><Reference><Citation>Fendrick A.M., Monto A.S., Nightengale B., Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch. Intern. Med. 2003;163:487&#x2013;494. doi: 10.1001/archinte.163.4.487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.163.4.487</ArticleId><ArticleId IdType="pubmed">12588210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy J.L., Turner R.B., Braciale T., Heymann P.W., Borish L. Pathogenesis of rhinovirus infection. Curr. Opin. Virol. 2012;2:287&#x2013;293. doi: 10.1016/j.coviro.2012.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.03.008</ArticleId><ArticleId IdType="pmc">PMC3378761</ArticleId><ArticleId IdType="pubmed">22542099</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox J.P. Is a rhinovirus vaccine possible? Am. J. Epidemiol. 1976;103:345&#x2013;354. doi: 10.1093/oxfordjournals.aje.a112233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a112233</ArticleId><ArticleId IdType="pubmed">176887</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston S.L. A, B &amp; C Rhinoviruses&#x2014;New Knowledge from an Impressive Consortium&#x2014;A Step Forward for Rhinovirus Vaccine Efforts, or a Step Back? Am. J. Respir. Crit. Care Med. 2021;203:786&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8017583</ArticleId><ArticleId IdType="pubmed">33600736</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi T., Devries M., Bacharier L.B., Busse W., Camargo C.A., Jr., Cohen R., Demuri G.P., Evans M.D., Fitzpatrick A.M., Gergen P.J., et al. Enhanced Neutralizing Antibody Responses to Rhinovirus C and Age-Dependent Patterns of Infection. Am. J. Respir. Crit. Care Med. 2021;203:822&#x2013;830. doi: 10.1164/rccm.202010-3753OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202010-3753OC</ArticleId><ArticleId IdType="pmc">PMC8017585</ArticleId><ArticleId IdType="pubmed">33357024</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooney M.K., Fox J.P., Kenny G.E. Antigenic groupings of 90 rhinovirus serotypes. Infect. Immun. 1982;37:642&#x2013;647. doi: 10.1128/iai.37.2.642-647.1982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.37.2.642-647.1982</ArticleId><ArticleId IdType="pmc">PMC347580</ArticleId><ArticleId IdType="pubmed">6288568</ArticleId></ArticleIdList></Reference><Reference><Citation>Edlmayr J., Niespodziana K., Popow-Kraupp T., Krzyzanek V., Focke-Tejkl M., Blaas D., Grote M., Valenta R. Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur. Respir. J. 2011;37:44&#x2013;52. doi: 10.1183/09031936.00149109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00149109</ArticleId><ArticleId IdType="pubmed">20530036</ArticleId></ArticleIdList></Reference><Reference><Citation>Katpally U., Fu T.M., Freed D.C., Casimiro D.R., Smith T.J. Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization. J. Virol. 2009;83:7040&#x2013;7048. doi: 10.1128/JVI.00557-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00557-09</ArticleId><ArticleId IdType="pmc">PMC2704786</ArticleId><ArticleId IdType="pubmed">19403680</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamory B.H., Hamparian V.V., Conant R.M., Gwaltney J.M., Jr. Human responses to two decavalent rhinovirus vaccines. J. Infect. Dis. 1975;132:623&#x2013;629. doi: 10.1093/infdis/132.6.623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/132.6.623</ArticleId><ArticleId IdType="pubmed">172561</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean G.R. Developing a vaccine for human rhinoviruses. J. Vaccines Immun. 2014;2:16&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4291752</ArticleId><ArticleId IdType="pubmed">25593706</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett N.W., Walton R.P., Edwards M.R., Aniscenko J., Caramori G., Zhu J., Glanville N., Choy K.J., Jourdan P., Burnet J., et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 2008;14:199&#x2013;204. doi: 10.1038/nm1713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1713</ArticleId><ArticleId IdType="pmc">PMC3384678</ArticleId><ArticleId IdType="pubmed">18246079</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaut H.J., De Palma A.M., Neyts J. Combating enterovirus replication: State-of-the-Art on antiviral research. Biochem. Pharmacol. 2012;83:185&#x2013;192. doi: 10.1016/j.bcp.2011.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2011.08.016</ArticleId><ArticleId IdType="pubmed">21889497</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Linden L., Wolthers K.C., van Kuppeveld F.J. Replication and Inhibitors of Enteroviruses and Parechoviruses. Viruses. 2015;7:4529&#x2013;4562. doi: 10.3390/v7082832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7082832</ArticleId><ArticleId IdType="pmc">PMC4576193</ArticleId><ArticleId IdType="pubmed">26266417</ArticleId></ArticleIdList></Reference><Reference><Citation>Staring J., von Castelmur E., Blomen V.A., van den Hengel L.G., Brockmann M., Baggen J., Thibaut H.J., Nieuwenhuis J., Janssen H., van Kuppeveld F.J., et al. PLA2G16 represents a switch between entry and clearance of Picornaviridae. Nature. 2017;541:412&#x2013;416. doi: 10.1038/nature21032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21032</ArticleId><ArticleId IdType="pubmed">28077878</ArticleId></ArticleIdList></Reference><Reference><Citation>Elling U., Wimmer R.A., Leibbrandt A., Burkard T., Michlits G., Leopoldi A., Micheler T., Abdeen D., Zhuk S., Aspalter I.M., et al. A reversible haploid mouse embryonic stem cell biobank resource for functional genomics. Nature. 2017;550:114&#x2013;118. doi: 10.1038/nature24027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24027</ArticleId><ArticleId IdType="pmc">PMC6235111</ArticleId><ArticleId IdType="pubmed">28953874</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova V., Sousa F.H., Stevens C., Barlow P.G. Antiviral therapeutic approaches for human rhinovirus infections. Future Virol. 2018;13:505&#x2013;518. doi: 10.2217/fvl-2018-0016.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl-2018-0016</ArticleId><ArticleId IdType="pmc">PMC6136076</ArticleId><ArticleId IdType="pubmed">30245735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Lyoo H., van der Schaar H.M., Strating J.R., van Kuppeveld F.J. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections. Curr. Opin. Virol. 2017;24:1&#x2013;8. doi: 10.1016/j.coviro.2017.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.03.009</ArticleId><ArticleId IdType="pmc">PMC7172203</ArticleId><ArticleId IdType="pubmed">28411509</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassauer A., Weinmuellner R., Meier C., Pretsch A., Prieschl-Grassauer E., Unger H. Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Virol. J. 2008;5:107. doi: 10.1186/1743-422X-5-107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-5-107</ArticleId><ArticleId IdType="pmc">PMC2562995</ArticleId><ArticleId IdType="pubmed">18817582</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagno V., Andreozzi P., D&#x2019;Alicarnasso M., Jacob Silva P., Mueller M., Galloux M., Le Goffic R., Jones S.T., Vallino M., Hodek J., et al. Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nat. Mater. 2018;17:195&#x2013;203. doi: 10.1038/nmat5053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmat5053</ArticleId><ArticleId IdType="pubmed">29251725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Santaquiteria M., Illescas B.M., Abdelnabi R., Boonen A., Mills A., Marti-Mari O., Noppen S., Neyts J., Schols D., Gago F., et al. Multivalent Tryptophan- and Tyrosine-Containing [60]Fullerene Hexa-Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors. Chemistry. 2021;27:10700&#x2013;10710. doi: 10.1002/chem.202101098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/chem.202101098</ArticleId><ArticleId IdType="pmc">PMC8361981</ArticleId><ArticleId IdType="pubmed">33851758</ArticleId></ArticleIdList></Reference><Reference><Citation>Real-Hohn A., Zhu R., Ganjian H., Ibrahim N., Hinterdorfer P., Kowalski H., Blaas D. Catching Common Cold Virus with a Net: Pyridostatin Forms Filaments in Tris Buffer That Trap Viruses-A Novel Antiviral Strategy? Viruses. 2020;12:723. doi: 10.3390/v12070723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12070723</ArticleId><ArticleId IdType="pmc">PMC7412420</ArticleId><ArticleId IdType="pubmed">32635420</ArticleId></ArticleIdList></Reference><Reference><Citation>Diana G.D., McKinlay M.A., Brisson C.J., Zalay E.S., Miralles J.V., Salvador U.J. Isoxazoles with antipicornavirus activity. J. Med. Chem. 1985;28:748&#x2013;752. doi: 10.1021/jm00383a010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm00383a010</ArticleId><ArticleId IdType="pubmed">2989517</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear D.C., Fancher M.J., Felock P.J., Rossmann M.G., Miller M.S., Diana G., Treasurywala A.M., McKinlay M.A., Dutko F.J. Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. J. Virol. 1989;63:2002&#x2013;2007. doi: 10.1128/jvi.63.5.2002-2007.1989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.63.5.2002-2007.1989</ArticleId><ArticleId IdType="pmc">PMC250615</ArticleId><ArticleId IdType="pubmed">2539499</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith T.J., Kremer M.J., Luo M., Vriend G., Arnold E., Kamer G., Rossmann M.G., McKinlay M.A., Diana G.D., Otto M.J. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science. 1986;233:1286&#x2013;1293. doi: 10.1126/science.3018924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3018924</ArticleId><ArticleId IdType="pubmed">3018924</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang A., Nanni R.G., Li T., Arnold G.F., Oren D.A., Jacobo-Molina A., Williams R.L., Kamer G., Rubenstein D.A., Li Y., et al. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14. J. Mol. Biol. 1993;230:857&#x2013;867. doi: 10.1006/jmbi.1993.1206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1993.1206</ArticleId><ArticleId IdType="pubmed">8386772</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods M.G., Diana G.D., Rogge M.C., Otto M.J., Dutko F.J., McKinlay M.A. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob. Agents Chemother. 1989;33:2069&#x2013;2074. doi: 10.1128/AAC.33.12.2069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.33.12.2069</ArticleId><ArticleId IdType="pmc">PMC172823</ArticleId><ArticleId IdType="pubmed">2559655</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang S.K., Cheh J., Isaacs L., Joseph-McCarthy D., Choi S.K., Pevear D.C., Whitesides G.M., Hogle J.M. A structurally biased combinatorial approach for discovering new anti-picornaviral compounds. Chem. Biol. 2001;8:33&#x2013;45. doi: 10.1016/S1074-5521(00)00053-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-5521(00)00053-3</ArticleId><ArticleId IdType="pubmed">11182317</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepard D.A., Heinz B.A., Rueckert R.R. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14. J. Virol. 1993;67:2245&#x2013;2254. doi: 10.1128/jvi.67.4.2245-2254.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.67.4.2245-2254.1993</ArticleId><ArticleId IdType="pmc">PMC240355</ArticleId><ArticleId IdType="pubmed">8383239</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann M.G. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids. Antivir. Res. 1989;11:3&#x2013;13. doi: 10.1016/0166-3542(89)90016-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-3542(89)90016-8</ArticleId><ArticleId IdType="pubmed">2540708</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenwirth B., Oren D.A., Arnold E., Kis Z.L., Eggers H.J. SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity. Antivir. Res. 1995;26:65&#x2013;82. doi: 10.1016/0166-3542(94)00066-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-3542(94)00066-H</ArticleId><ArticleId IdType="pubmed">7741522</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Yap M.L., Cardosa J., Kuhn R.J., Rossmann M.G. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc. Natl. Acad. Sci. USA. 2013;110:5463&#x2013;5467. doi: 10.1073/pnas.1222379110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222379110</ArticleId><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="pubmed">23509286</ArticleId></ArticleIdList></Reference><Reference><Citation>Diana G.D., Otto M.J., McKinlay M.A. Inhibitors of picornavirus uncoating as antiviral agents. Pharmacol. Ther. 1985;29:287&#x2013;297. doi: 10.1016/0163-7258(85)90005-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0163-7258(85)90005-1</ArticleId><ArticleId IdType="pubmed">3014575</ArticleId></ArticleIdList></Reference><Reference><Citation>Okun V.M., Nizet S., Blaas D., Kenndler E. Kinetics of thermal denaturation of human rhinoviruses in the presence of anti-viral capsid binders analyzed by capillary electrophoresis. Electrophoresis. 2002;23:896&#x2013;902. doi: 10.1002/1522-2683(200203)23:6&lt;896::AID-ELPS896&gt;3.0.CO;2-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1522-2683(200203)23:6&lt;896::AID-ELPS896&gt;3.0.CO;2-W</ArticleId><ArticleId IdType="pubmed">11920874</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelps D.K., Post C.B. Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus. Protein Sci. 1999;8:2281&#x2013;2289. doi: 10.1110/ps.8.11.2281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.8.11.2281</ArticleId><ArticleId IdType="pmc">PMC2144186</ArticleId><ArticleId IdType="pubmed">10595531</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelps D.K., Post C.B. A novel basis of capsid stabilization by antiviral compounds. J. Mol. Biol. 1995;254:544&#x2013;551. doi: 10.1006/jmbi.1995.0637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1995.0637</ArticleId><ArticleId IdType="pubmed">7500332</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald J., Pasin M., Richter M., Walther C., Mathai N., Kirchmair J., Makarov V.A., Goessweiner-Mohr N., Marlovits T.C., Zanella I., et al. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site. Proc. Natl. Acad. Sci. USA. 2019;116:19109&#x2013;19115. doi: 10.1073/pnas.1904732116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1904732116</ArticleId><ArticleId IdType="pmc">PMC6754595</ArticleId><ArticleId IdType="pubmed">31462495</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelnabi R., Geraets J.A., Ma Y., Mirabelli C., Flatt J.W., Domanska A., Delang L., Jochmans D., Kumar T.A., Jayaprakash V., et al. A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. PLoS Biol. 2019;17:e3000281. doi: 10.1371/journal.pbio.3000281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000281</ArticleId><ArticleId IdType="pmc">PMC6559632</ArticleId><ArticleId IdType="pubmed">31185007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Wang Y., He W., Sun Y., Guo Y., Zhong W., Gao Q., Liao M., Wang X., Cai Y., et al. Design, Synthesis, and Evaluation of Novel Enterovirus 71 Inhibitors as Therapeutic Drug Leads for the Treatment of Human Hand, Foot, and Mouth Disease. J. Med. Chem. 2020;63:1233&#x2013;1244. doi: 10.1021/acs.jmedchem.9b01414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.9b01414</ArticleId><ArticleId IdType="pubmed">31939669</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Sheng J., van Vliet A.L.W., Buda G., van Kuppeveld F.J.M., Rossmann M.G. Molecular basis for the acid-initiated uncoating of human enterovirus D68. Proc. Natl. Acad. Sci. USA. 2018;115:E12209&#x2013;E12217. doi: 10.1073/pnas.1803347115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1803347115</ArticleId><ArticleId IdType="pmc">PMC6310856</ArticleId><ArticleId IdType="pubmed">30530701</ArticleId></ArticleIdList></Reference><Reference><Citation>Garriga D., Pickl-Herk A., Luque D., Wruss J., Caston J.R., Blaas D., Verdaguer N. Insights into minor group rhinovirus uncoating: The X-ray structure of the HRV2 empty capsid. PLoS Pathog. 2012;8:e1002473. doi: 10.1371/journal.ppat.1002473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002473</ArticleId><ArticleId IdType="pmc">PMC3252380</ArticleId><ArticleId IdType="pubmed">22241997</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickl-Herk A., Luque D., Vives-Adrian L., Querol-Audi J., Garriga D., Trus B.L., Verdaguer N., Blaas D., Caston J.R. Uncoating of common cold virus is preceded by RNA switching as determined by X-ray and cryo-EM analyses of the subviral A-particle. Proc. Natl. Acad. Sci. USA. 2013;110:20063&#x2013;20068. doi: 10.1073/pnas.1312128110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312128110</ArticleId><ArticleId IdType="pmc">PMC3864292</ArticleId><ArticleId IdType="pubmed">24277846</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy H.C., Bostina M., Filman D.J., Hogle J.M. Catching a virus in the act of RNA release: A novel poliovirus uncoating intermediate characterized by cryo-electron microscopy. J. Virol. 2010;84:4426&#x2013;4441. doi: 10.1128/JVI.02393-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02393-09</ArticleId><ArticleId IdType="pmc">PMC2863768</ArticleId><ArticleId IdType="pubmed">20181687</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L., Sun Y., Fan J., Zhu B., Cao L., Gao Q., Zhang Y., Liu H., Rao Z., Wang X. Structures of Coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating. Nat. Commun. 2018;9:4985. doi: 10.1038/s41467-018-07531-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07531-0</ArticleId><ArticleId IdType="pmc">PMC6255764</ArticleId><ArticleId IdType="pubmed">30478256</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson S.D. Kinetic models for receptor-catalyzed conversion of coxsackievirus B3 to A-particles. J. Virol. 2014;88:11568&#x2013;11575. doi: 10.1128/JVI.01790-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01790-14</ArticleId><ArticleId IdType="pmc">PMC4178797</ArticleId><ArticleId IdType="pubmed">25078690</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu K., Ding J., Han J.F., Zhang Y., Wu X.Y., He Y.L., Qin C.F., Chen R. Human enterovirus 71 uncoating captured at atomic resolution. J. Virol. 2014;88:3114&#x2013;3126. doi: 10.1128/JVI.03029-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03029-13</ArticleId><ArticleId IdType="pmc">PMC3957924</ArticleId><ArticleId IdType="pubmed">24352461</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J., Wang X., Hu Z., Gao Q., Sun Y., Li X., Porta C., Walter T.S., Gilbert R.J., Zhao Y., et al. Picornavirus uncoating intermediate captured in atomic detail. Nat. Commun. 2013;4:1929. doi: 10.1038/ncomms2889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2889</ArticleId><ArticleId IdType="pmc">PMC3709478</ArticleId><ArticleId IdType="pubmed">23728514</ArticleId></ArticleIdList></Reference><Reference><Citation>Casasnovas J.M., Springer T.A. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): An intermediate in which ICAM-1 is bound and RNA is released. J. Virol. 1994;68:5882&#x2013;5889. doi: 10.1128/jvi.68.9.5882-5889.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.68.9.5882-5889.1994</ArticleId><ArticleId IdType="pmc">PMC236993</ArticleId><ArticleId IdType="pubmed">7914550</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoover-Litty H., Greve J.M. Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion. J. Virol. 1993;67:390&#x2013;397. doi: 10.1128/jvi.67.1.390-397.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.67.1.390-397.1993</ArticleId><ArticleId IdType="pmc">PMC237375</ArticleId><ArticleId IdType="pubmed">8093221</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing L., Casasnovas J.M., Cheng R.H. Structural analysis of human rhinovirus complexed with ICAM-1 reveals the dynamics of receptor-mediated virus uncoating. J. Virol. 2003;77:6101&#x2013;6107. doi: 10.1128/JVI.77.11.6101-6107.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.11.6101-6107.2003</ArticleId><ArticleId IdType="pmc">PMC155003</ArticleId><ArticleId IdType="pubmed">12743267</ArticleId></ArticleIdList></Reference><Reference><Citation>Konecsni T., Berka U., Pickl-Herk A., Bilek G., Khan A.G., Gajdzig L., Fuchs R., Blaas D. Low pH-triggered beta-propeller switch of the low-density lipoprotein receptor assists rhinovirus infection. J. Virol. 2009;83:10922&#x2013;10930. doi: 10.1128/JVI.01312-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01312-09</ArticleId><ArticleId IdType="pmc">PMC2772763</ArticleId><ArticleId IdType="pubmed">19706701</ArticleId></ArticleIdList></Reference><Reference><Citation>Prchla E., Kuechler E., Blaas D., Fuchs R. Uncoating of human rhinovirus serotype 2 from late endosomes. J. Virol. 1994;68:3713&#x2013;3723. doi: 10.1128/jvi.68.6.3713-3723.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.68.6.3713-3723.1994</ArticleId><ArticleId IdType="pmc">PMC236876</ArticleId><ArticleId IdType="pubmed">8189509</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhamedova L., Fuzik T., Novacek J., Hrebik D., Pridal A., Marti G.A., Guerin D.M.A., Plevka P. Virion structure and in vitro genome release mechanism of dicistrovirus Kashmir bee virus. J. Virol. 2021;95:e01950-20. doi: 10.1128/JVI.01950-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01950-20</ArticleId><ArticleId IdType="pmc">PMC8139710</ArticleId><ArticleId IdType="pubmed">33658338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalynych S., Fuzik T., Pridal A., de Miranda J., Plevka P. Cryo-EM study of slow bee paralysis virus at low pH reveals iflavirus genome release mechanism. Proc. Natl. Acad. Sci. USA. 2017;114:598&#x2013;603. doi: 10.1073/pnas.1616562114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1616562114</ArticleId><ArticleId IdType="pmc">PMC5255585</ArticleId><ArticleId IdType="pubmed">28053231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Eugenia R., Durana A., Lopez-Marijuan I., Marti G.A., Guerin D.M.A. X-ray structure of Triatoma virus empty capsid: Insights into the mechanism of uncoating and RNA release in dicistroviruses. J. Gen. Virol. 2016;97:2769&#x2013;2779. doi: 10.1099/jgv.0.000580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000580</ArticleId><ArticleId IdType="pubmed">27519423</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchta D., Fuzik T., Hrebik D., Levdansky Y., Sukenik L., Mukhamedova L., Moravcova J., Vacha R., Plevka P. Enterovirus particles expel capsid pentamers to enable genome release. Nat. Commun. 2019;10:1138. doi: 10.1038/s41467-019-09132-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09132-x</ArticleId><ArticleId IdType="pmc">PMC6408523</ArticleId><ArticleId IdType="pubmed">30850609</ArticleId></ArticleIdList></Reference><Reference><Citation>Agirre J., Aloria K., Arizmendi J.M., Iloro I., Elortza F., Sanchez-Eugenia R., Marti G.A., Neumann E., Rey F.A., Guerin D.M. Capsid protein identification and analysis of mature Triatoma virus (TrV) virions and naturally occurring empty particles. Virology. 2011;409:91&#x2013;101. doi: 10.1016/j.virol.2010.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.09.034</ArticleId><ArticleId IdType="pubmed">21030058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonberg-Holm K., Noble-Harvey J. Comparison of in vitro and cell-mediated alteration of a human Rhinovirus and its inhibition by sodium dodecyl sulfate. J. Virol. 1973;12:819&#x2013;826. doi: 10.1128/jvi.12.4.819-826.1973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.12.4.819-826.1973</ArticleId><ArticleId IdType="pmc">PMC356699</ArticleId><ArticleId IdType="pubmed">4359954</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonberg-Holm K., Yin F.H. Antigenic determinants of infective and inactivated human rhinovirus type 2. J. Virol. 1973;12:114&#x2013;123. doi: 10.1128/jvi.12.1.114-123.1973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.12.1.114-123.1973</ArticleId><ArticleId IdType="pmc">PMC355237</ArticleId><ArticleId IdType="pubmed">4126195</ArticleId></ArticleIdList></Reference><Reference><Citation>Snijder J., Uetrecht C., Rose R.J., Sanchez-Eugenia R., Marti G.A., Agirre J., Guerin D.M., Wuite G.J., Heck A.J., Roos W.H. Probing the biophysical interplay between a viral genome and its capsid. Nat. Chem. 2013;5:502&#x2013;509. doi: 10.1038/nchem.1627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchem.1627</ArticleId><ArticleId IdType="pubmed">23695632</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaut H.J., Lacroix C., De Palma A.M., Franco D., Decramer M., Neyts J. Toward antiviral therapy/prophylaxis for rhinovirus-induced exacerbations of chronic obstructive pulmonary disease: Challenges, opportunities, and strategies. Rev. Med. Virol. 2016;26:21&#x2013;33. doi: 10.1002/rmv.1856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1856</ArticleId><ArticleId IdType="pmc">PMC7169185</ArticleId><ArticleId IdType="pubmed">26388447</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotbart H.A., Webster A.D., Pleconaril Treatment Registry G. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin. Infect. Dis. 2001;32:228&#x2013;235. doi: 10.1086/318452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318452</ArticleId><ArticleId IdType="pubmed">11170912</ArticleId></ArticleIdList></Reference><Reference><Citation>Radanovic I., Rkman D., Zekan P., Kutlesa M., Barsic B. Chronic meningoencephalitis caused by Echo virus 6 in a patient with common variable immunodeficiency: Successful treatment with pleconaril. Wien. Klin. Wochenschr. 2018;130:70&#x2013;72. doi: 10.1007/s00508-017-1289-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-017-1289-5</ArticleId><ArticleId IdType="pubmed">29116409</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Sheng J., Fokine A., Meng G., Shin W.H., Long F., Kuhn R.J., Kihara D., Rossmann M.G. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science. 2015;347:71&#x2013;74. doi: 10.1126/science.1261962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1261962</ArticleId><ArticleId IdType="pmc">PMC4307789</ArticleId><ArticleId IdType="pubmed">25554786</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden F.G., Herrington D.T., Coats T.L., Kim K., Cooper E.C., Villano S.A., Liu S., Hudson S., Pevear D.C., Collett M., et al. Pleconaril Respiratory Infection Study, G., Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: Results of 2 double-blind, randomized, placebo-controlled trials. Clin. Infect. Dis. 2003;36:1523&#x2013;1532. doi: 10.1086/375069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/375069</ArticleId><ArticleId IdType="pmc">PMC7199898</ArticleId><ArticleId IdType="pubmed">12802751</ArticleId></ArticleIdList></Reference><Reference><Citation>Feil S.C., Hamilton S., Krippner G.Y., Lin B., Luttick A., McConnell D.B., Nearn R., Parker M.W., Ryan J., Stanislawski P.C., et al. An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus. ACS Med. Chem. Lett. 2012;3:303&#x2013;307. doi: 10.1021/ml2002955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ml2002955</ArticleId><ArticleId IdType="pmc">PMC4025830</ArticleId><ArticleId IdType="pubmed">24900468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiremath C.N., Filman D.J., Grant R.A., Hogle J.M. Ligand-induced conformational changes in poliovirus-antiviral drug complexes. Acta Crystallogr. D Biol. Crystallogr. 1997;53 Pt 5:558&#x2013;570. doi: 10.1107/S0907444997000954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444997000954</ArticleId><ArticleId IdType="pubmed">15299887</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant R.A., Hiremath C.N., Filman D.J., Syed R., Andries K., Hogle J.M. Structures of poliovirus complexes with anti-viral drugs: Implications for viral stability and drug design. Curr. Biol. CB. 1994;4:784&#x2013;797. doi: 10.1016/S0960-9822(00)00176-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(00)00176-7</ArticleId><ArticleId IdType="pubmed">7820548</ArticleId></ArticleIdList></Reference><Reference><Citation>Andries K., Dewindt B., Snoeks J., Willebrords R., van Eemeren K., Stokbroekx R., Janssen P.A. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity. Antimicrob. Agents Chemother. 1992;36:100&#x2013;107. doi: 10.1128/AAC.36.1.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.36.1.100</ArticleId><ArticleId IdType="pmc">PMC189235</ArticleId><ArticleId IdType="pubmed">1317142</ArticleId></ArticleIdList></Reference><Reference><Citation>Lentz K.N., Smith A.D., Geisler S.C., Cox S., Buontempo P., Skelton A., DeMartino J., Rozhon E., Schwartz J., Girijavallabhan V., et al. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: Comparison of the structural and biological properties of three poliovirus serotypes. Structure. 1997;5:961&#x2013;978. doi: 10.1016/S0969-2126(97)00249-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0969-2126(97)00249-9</ArticleId><ArticleId IdType="pubmed">9261087</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendry E., Hatanaka H., Fry E., Smyth M., Tate J., Stanway G., Santti J., Maaronen M., Hyypia T., Stuart D. The crystal structure of coxsackievirus A9: New insights into the uncoating mechanisms of enteroviruses. Structure. 1999;7:1527&#x2013;1538. doi: 10.1016/S0969-2126(00)88343-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0969-2126(00)88343-4</ArticleId><ArticleId IdType="pubmed">10647183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiremath C.N., Grant R.A., Filman D.J., Hogle J.M. Binding of the antiviral drug WIN51711 to the sabin strain of type 3 poliovirus: Structural comparison with drug binding in rhinovirus 14. Acta Crystallogr. D Biol. Crystallogr. 1995;51 Pt 4:473&#x2013;489. doi: 10.1107/S090744499401084X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S090744499401084X</ArticleId><ArticleId IdType="pubmed">15299834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield A.T., Diana G.D., Rossmann M.G. Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16. Proc. Natl. Acad. Sci. USA. 1999;96:14730&#x2013;14735. doi: 10.1073/pnas.96.26.14730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.26.14730</ArticleId><ArticleId IdType="pmc">PMC24716</ArticleId><ArticleId IdType="pubmed">10611281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield A.T., Lee W., Zhao R., Oliveira M.A., Minor I., Rueckert R.R., Rossmann M.G. The refined structure of human rhinovirus 16 at 2.15 A resolution: Implications for the viral life cycle. Structure. 1997;5:427&#x2013;441. doi: 10.1016/S0969-2126(97)00199-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0969-2126(97)00199-8</ArticleId><ArticleId IdType="pubmed">9083115</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Simpson A.A., Ledford R.M., Bator C.M., Chakravarty S., Skochko G.A., Demenczuk T.M., Watanyar A., Pevear D.C., Rossmann M.G. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds. J. Virol. 2004;78:11061&#x2013;11069. doi: 10.1128/JVI.78.20.11061-11069.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.20.11061-11069.2004</ArticleId><ArticleId IdType="pmc">PMC521849</ArticleId><ArticleId IdType="pubmed">15452226</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen L.M., Walker E.J., Jans D.A., Ghildyal R. Proteases of human rhinovirus: Role in infection. Methods Mol. Biol. 2015;1221:129&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">25261311</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold E., Luo M., Vriend G., Rossmann M.G., Palmenberg A.C., Parks G.D., Nicklin M.J., Wimmer E. Implications of the picornavirus capsid structure for polyprotein processing. Proc. Natl. Acad. Sci. USA. 1987;84:21&#x2013;25. doi: 10.1073/pnas.84.1.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.84.1.21</ArticleId><ArticleId IdType="pmc">PMC304133</ArticleId><ArticleId IdType="pubmed">3467351</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards A.L., Jackson W.T. Intracellular vesicle acidification promotes maturation of infectious poliovirus particles. PLoS Pathog. 2012;8:e1003046. doi: 10.1371/journal.ppat.1003046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003046</ArticleId><ArticleId IdType="pmc">PMC3510256</ArticleId><ArticleId IdType="pubmed">23209416</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighat A., Svitkin Y., Novoa I., Kuechler E., Skern T., Sonenberg N. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J. Virol. 1996;70:8444&#x2013;8450. doi: 10.1128/jvi.70.12.8444-8450.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.70.12.8444-8450.1996</ArticleId><ArticleId IdType="pmc">PMC190934</ArticleId><ArticleId IdType="pubmed">8970966</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies M.V., Pelletier J., Meerovitch K., Sonenberg N., Kaufman R.J. The effect of poliovirus proteinase 2Apro expression on cellular metabolism. Inhibition of DNA replication, RNA polymerase II transcription, and translation. J. Biol. Chem. 1991;266:14714&#x2013;14720. doi: 10.1016/S0021-9258(18)98745-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)98745-4</ArticleId><ArticleId IdType="pubmed">1713590</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamphear B.J., Yan R., Yang F., Waters D., Liebig H.D., Klump H., Kuechler E., Skern T., Rhoads R.E. Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. J. Biol. Chem. 1993;268:19200&#x2013;19203. doi: 10.1016/S0021-9258(19)36499-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)36499-3</ArticleId><ArticleId IdType="pubmed">8396129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommergruber W., Ahorn H., Zophel A., Maurer-Fogy I., Fessl F., Schnorrenberg G., Liebig H.D., Blaas D., Kuechler E., Skern T. Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A. J. Biol. Chem. 1992;267:22639&#x2013;22644. doi: 10.1016/S0021-9258(18)41720-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)41720-6</ArticleId><ArticleId IdType="pubmed">1331062</ArticleId></ArticleIdList></Reference><Reference><Citation>Skern T., Sommergruber W., Auer H., Volkmann P., Zorn M., Liebig H.D., Fessl F., Blaas D., Kuechler E. Substrate requirements of a human rhinoviral 2A proteinase. Virology. 1991;181:46&#x2013;54. doi: 10.1016/0042-6822(91)90468-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(91)90468-Q</ArticleId><ArticleId IdType="pubmed">1847268</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommergruber W., Zorn M., Blaas D., Fessl F., Volkmann P., Maurer-Fogy I., Pallai P., Merluzzi V., Matteo M., Skern T., et al. Polypeptide 2A of human rhinovirus type 2: Identification as a protease and characterization by mutational analysis. Virology. 1989;169:68&#x2013;77. doi: 10.1016/0042-6822(89)90042-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(89)90042-1</ArticleId><ArticleId IdType="pubmed">2538037</ArticleId></ArticleIdList></Reference><Reference><Citation>Seipelt J., Liebig H.D., Sommergruber W., Gerner C., Kuechler E. 2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells. J. Biol. Chem. 2000;275:20084&#x2013;20089. doi: 10.1074/jbc.275.26.20084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.275.26.20084</ArticleId><ArticleId IdType="pubmed">10867028</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J., Zhang J., Yanagawa B., Luo Z., Yang X., Chang J., McManus B., Luo H. Cleavage of serum response factor mediated by enteroviral protease 2A contributes to impaired cardiac function. Cell Res. 2012;22:360&#x2013;371. doi: 10.1038/cr.2011.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2011.114</ArticleId><ArticleId IdType="pmc">PMC3271589</ArticleId><ArticleId IdType="pubmed">21769134</ArticleId></ArticleIdList></Reference><Reference><Citation>Krenn B.M., Gaudernak E., Holzer B., Lanke K., Van Kuppeveld F.J., Seipelt J. Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections. J. Virol. 2009;83:58&#x2013;64. doi: 10.1128/JVI.01543-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01543-08</ArticleId><ArticleId IdType="pmc">PMC2612303</ArticleId><ArticleId IdType="pubmed">18922875</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudernak E., Seipelt J., Triendl A., Grassauer A., Kuechler E. Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses. J. Virol. 2002;76:6004&#x2013;6015. doi: 10.1128/JVI.76.12.6004-6015.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.12.6004-6015.2002</ArticleId><ArticleId IdType="pmc">PMC136215</ArticleId><ArticleId IdType="pubmed">12021333</ArticleId></ArticleIdList></Reference><Reference><Citation>Molla A., Hellen C.U., Wimmer E. Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors. J. Virol. 1993;67:4688&#x2013;4695. doi: 10.1128/jvi.67.8.4688-4695.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.67.8.4688-4695.1993</ArticleId><ArticleId IdType="pmc">PMC237854</ArticleId><ArticleId IdType="pubmed">8392608</ArticleId></ArticleIdList></Reference><Reference><Citation>Deszcz L., Seipelt J., Vassilieva E., Roetzer A., Kuechler E. Antiviral activity of caspase inhibitors: Effect on picornaviral 2A proteinase. FEBS Lett. 2004;560:51&#x2013;55. doi: 10.1016/S0014-5793(04)00069-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(04)00069-9</ArticleId><ArticleId IdType="pubmed">14987997</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Manganaro R., Zonsics B., Hurdiss D.L., Zwaagstra M., Donselaar T., Welter N.G.E., van Kleef R., Lopez M.L., Bevilacqua F., et al. Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C. PLoS Biol. 2020;18:e3000904. doi: 10.1371/journal.pbio.3000904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000904</ArticleId><ArticleId IdType="pmc">PMC7673538</ArticleId><ArticleId IdType="pubmed">33156822</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Manganaro R., Zonsics B., Strating J., El Kazzi P., Lorenzo Lopez M., Ulferts R., van Hoey C., Mate M.J., Langer T., et al. Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner. ACS Infect. Dis. 2019;5:1609&#x2013;1623. doi: 10.1021/acsinfecdis.9b00179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.9b00179</ArticleId><ArticleId IdType="pmc">PMC6747591</ArticleId><ArticleId IdType="pubmed">31305993</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz B.A., Vance L.M. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus. J. Virol. 1995;69:4189&#x2013;4197. doi: 10.1128/jvi.69.7.4189-4197.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.7.4189-4197.1995</ArticleId><ArticleId IdType="pmc">PMC189156</ArticleId><ArticleId IdType="pubmed">7769678</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragovich P.S., Prins T.J., Zhou R., Webber S.E., Marakovits J.T., Fuhrman S.A., Patick A.K., Matthews D.A., Lee C.A., Ford C.E., et al. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. J. Med. Chem. 1999;42:1213&#x2013;1224. doi: 10.1021/jm9805384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm9805384</ArticleId><ArticleId IdType="pubmed">10197965</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden F.G., Turner R.B., Gwaltney J.M., Chi-Burris K., Gersten M., Hsyu P., Patick A.K., Smith G.J., 3rd, Zalman L.S. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob. Agents Chemother. 2003;47:3907&#x2013;3916. doi: 10.1128/AAC.47.12.3907-3916.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.47.12.3907-3916.2003</ArticleId><ArticleId IdType="pmc">PMC296196</ArticleId><ArticleId IdType="pubmed">14638501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix C., George S., Leyssen P., Hilgenfeld R., Neyts J. The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir. Antimicrob. Agents Chemother. 2015;59:5814&#x2013;5818. doi: 10.1128/AAC.00534-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00534-15</ArticleId><ArticleId IdType="pmc">PMC4538484</ArticleId><ArticleId IdType="pubmed">26055377</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen D.O., Murray B.K., Robins R.K., North J.A. In vitro Antiviral Activity of Ribavirin against Picornaviruses. Antivir. Chem. Chemother. 1992;3:361&#x2013;370. doi: 10.1177/095632029200300606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/095632029200300606</ArticleId></ArticleIdList></Reference><Reference><Citation>Smee D.F., Evans W.J., Nicolaou K.C., Tarbet E.B., Day C.W. Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds. Antivir. Res. 2016;131:61&#x2013;65. doi: 10.1016/j.antiviral.2016.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.04.003</ArticleId><ArticleId IdType="pmc">PMC5100981</ArticleId><ArticleId IdType="pubmed">27063860</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuta Y., Takahashi K., Fukuda Y., Kuno M., Kamiyama T., Kozaki K., Nomura N., Egawa H., Minami S., Watanabe Y., et al. In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob. Agents Chemother. 2002;46:977&#x2013;981. doi: 10.1128/AAC.46.4.977-981.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.46.4.977-981.2002</ArticleId><ArticleId IdType="pmc">PMC127093</ArticleId><ArticleId IdType="pubmed">11897578</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirwan S., Kakkar R. Rhinovirus RNA Polymerase: Structure, Function, and Inhibitors. Viral Polym. 2019;10:301&#x2013;331. doi: 10.1016/B978-0-12-815422-9.00011-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-815422-9.00011-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholle M.D., McLaughlin D., Gurard-Levin Z.A. High-Throughput Affinity Selection Mass Spectrometry Using SAMDI-MS to Identify Small-Molecule Binders of the Human Rhinovirus 3C Protease. SLAS Discov. 2021;26:24725552211023211. doi: 10.1177/24725552211023211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/24725552211023211</ArticleId><ArticleId IdType="pubmed">34151629</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S., Fan K., Chen Z., Sun Y., Hou H., Zhu L. Structure of the HRV-C 3C-Rupintrivir Complex Provides New Insights for Inhibitor Design. Virol Sin. 2020;35:445&#x2013;454. doi: 10.1007/s12250-020-00196-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00196-4</ArticleId><ArticleId IdType="pmc">PMC7462945</ArticleId><ArticleId IdType="pubmed">32103448</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanga Q.M., Chen S.H. Human rhinovirus 3C protease as a potential target for the development of antiviral agents. Curr. Protein Pept. Sci. 2007;8:19&#x2013;27. doi: 10.2174/138920307779941523.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920307779941523</ArticleId><ArticleId IdType="pubmed">17305557</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q.M. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections. In: Jucker E., editor. Progress in Drug Research. Volume 52. Springer; Berlin/Heidelberg, Germany: 2001. p. 23.</Citation><ArticleIdList><ArticleId IdType="pubmed">11548209</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews D.A., Smith W.W., Ferre R.A., Condon B., Budahazi G., Sisson W., Villafranca J.E., Janson C.A., McElroy H.E., Gribskov C.L., et al. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell. 1994;77:761&#x2013;771. doi: 10.1016/0092-8674(94)90059-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(94)90059-0</ArticleId><ArticleId IdType="pubmed">7515772</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommergruber W., Seipelt J., Fessl F., Skern T., Liebig H.D., Casari G. Mutational analyses support a model for the HRV2 2A proteinase. Virology. 1997;234:203&#x2013;214. doi: 10.1006/viro.1997.8595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1997.8595</ArticleId><ArticleId IdType="pubmed">9268151</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Schaar H.M., Dorobantu C.M., Albulescu L., Strating J., van Kuppeveld F.J.M. Fat(al) attraction: Picornaviruses Usurp Lipid Transfer at Membrane Contact Sites to Create Replication Organelles. Trends Microbiol. 2016;24:535&#x2013;546. doi: 10.1016/j.tim.2016.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2016.02.017</ArticleId><ArticleId IdType="pmc">PMC7126954</ArticleId><ArticleId IdType="pubmed">27020598</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov G.A. Dynamic lipid landscape of picornavirus replication organelles. Curr. Opin. Virol. 2016;19:1&#x2013;6. doi: 10.1016/j.coviro.2016.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2016.05.003</ArticleId><ArticleId IdType="pmc">PMC9004531</ArticleId><ArticleId IdType="pubmed">27240115</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Linden L., Vives-Adrian L., Selisko B., Ferrer-Orta C., Liu X., Lanke K., Ulferts R., De Palma A.M., Tanchis F., Goris N., et al. The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family. PLoS Pathog. 2015;11:e1004733. doi: 10.1371/journal.ppat.1004733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004733</ArticleId><ArticleId IdType="pmc">PMC4370873</ArticleId><ArticleId IdType="pubmed">25799064</ArticleId></ArticleIdList></Reference><Reference><Citation>Rightsel W.A., Dice J.R., Mc A.R., Timm E.A., Mc L.I., Jr., Dixon G.J., Schabel F.M., Jr. Antiviral effect of guanidine. Science. 1961;134:558&#x2013;559. doi: 10.1126/science.134.3478.558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.134.3478.558</ArticleId><ArticleId IdType="pubmed">13741634</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganaro R., Zonsics B., Bauer L., Lorenzo Lopez M., Donselaar T., Zwaagstra M., Saporito F., Ferla S., Strating J., Coutard B., et al. Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors. Antivir. Res. 2020;178:104781. doi: 10.1016/j.antiviral.2020.104781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104781</ArticleId><ArticleId IdType="pubmed">32234539</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Q., Xu Z., Jin M., Shu T., Chen Y., Feng L., Zhang Q., Lan K., Wu S., Zhou H.B. Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: In vitro, in vivo, and combination therapy study. Eur. J. Med. Chem. 2020;202:112310. doi: 10.1016/j.ejmech.2020.112310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112310</ArticleId><ArticleId IdType="pubmed">32619885</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Liu Y., Lyoo H., van Vliet A.L.W., Wahedi M., de Bruin J.W., Roberts R.W., Overduin P., Meijer A., Rossmann M.G., et al. Bypassing pan-enterovirus host factor PLA2G16. Nat. Commun. 2019;10:3171. doi: 10.1038/s41467-019-11256-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11256-z</ArticleId><ArticleId IdType="pmc">PMC6639302</ArticleId><ArticleId IdType="pubmed">31320648</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Mock E.D., Martella A., Kantae V., Di X., Burggraaff L., Baggelaar M.P., Al-Ayed K., Bakker A., Florea B.I., et al. Activity-Based Protein Profiling Identifies alpha-Ketoamides as Inhibitors for Phospholipase A2 Group XVI. ACS Chem. Biol. 2019;14:164&#x2013;169. doi: 10.1021/acschembio.8b00969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.8b00969</ArticleId><ArticleId IdType="pmc">PMC6379856</ArticleId><ArticleId IdType="pubmed">30620559</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaworski K., Ahmadian M., Duncan R.E., Sarkadi-Nagy E., Varady K.A., Hellerstein M.K., Lee H.Y., Samuel V.T., Shulman G.I., Kim K.H., et al. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat. Med. 2009;15:159&#x2013;168. doi: 10.1038/nm.1904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1904</ArticleId><ArticleId IdType="pmc">PMC2863116</ArticleId><ArticleId IdType="pubmed">19136964</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou Y.L., Lin Y.W., Chang H.W., Lin H.Y., Shao H.Y., Yu S.L., Liu C.C., Chitra E., Sia C., Chow Y.H. Heat shock protein 90: Role in enterovirus 71 entry and assembly and potential target for therapy. PLoS ONE. 2013;8:e77133. doi: 10.1371/journal.pone.0077133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077133</ArticleId><ArticleId IdType="pmc">PMC3788750</ArticleId><ArticleId IdType="pubmed">24098578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R.Y., Kuo R.L., Ma W.C., Huang H.I., Yu J.S., Yen S.M., Huang C.R., Shih S.R. Heat shock protein-90-beta facilitates enterovirus 71 viral particles assembly. Virology. 2013;443:236&#x2013;247. doi: 10.1016/j.virol.2013.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2013.05.001</ArticleId><ArticleId IdType="pubmed">23711381</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.P., Shan G.Z., Peng Z.G., Zhu J.H., Meng S., Zhang T., Gao L.Y., Tao P.Z., Gao R.M., Li Y.H., et al. Synthesis and biological evaluation of heat-shock protein 90 inhibitors: Geldanamycin derivatives with broad antiviral activities. Antivir. Chem. Chemother. 2010;20:259&#x2013;268. doi: 10.3851/IMP1631.</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP1631</ArticleId><ArticleId IdType="pubmed">20710066</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.H., Shim A., Kim Y.J., Ahn J.H., Kwon B.E., Pham T.T., Lee J., Chang S.Y., Ko H.J. Antiviral and Anti-Inflammatory Activities of Pochonin D, a Heat Shock Protein 90 Inhibitor, against Rhinovirus Infection. Biomol. Ther. 2018;26:576&#x2013;583. doi: 10.4062/biomolther.2017.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.4062/biomolther.2017.233</ArticleId><ArticleId IdType="pmc">PMC6254639</ArticleId><ArticleId IdType="pubmed">29715717</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Ferla S., Head S.A., Bhat S., Pasunooti K.K., Shi W.Q., Albulescu L., Liu J.O., Brancale A., van Kuppeveld F.J.M., et al. Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP) Antivir. Res. 2018;156:55&#x2013;63. doi: 10.1016/j.antiviral.2018.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.05.010</ArticleId><ArticleId IdType="pubmed">29807040</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbic Ramljak I., Stanger J., Real-Hohn A., Dreier D., Wimmer L., Redlberger-Fritz M., Fischl W., Klingel K., Mihovilovic M.D., Blaas D., et al. Cellular N-myristoyltransferases play a crucial picornavirus genus-specific role in viral assembly, virion maturation, and infectivity. PLoS Pathog. 2018;14:e1007203. doi: 10.1371/journal.ppat.1007203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007203</ArticleId><ArticleId IdType="pmc">PMC6089459</ArticleId><ArticleId IdType="pubmed">30080883</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousnier A., Bell A.S., Swieboda D.P., Morales-Sanfrutos J., Perez-Dorado I., Brannigan J.A., Newman J., Ritzefeld M., Hutton J.A., Guedan A., et al. Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus. Nat. Chem. 2018;10:599&#x2013;606. doi: 10.1038/s41557-018-0039-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41557-018-0039-2</ArticleId><ArticleId IdType="pmc">PMC6015761</ArticleId><ArticleId IdType="pubmed">29760414</ArticleId></ArticleIdList></Reference><Reference><Citation>Majee P., Pattnaik A., Sahoo B.R., Shankar U., Pattnaik A.K., Kumar A., Nayak D. Inhibition of Zika virus replication by G-quadruplex-binding ligands. Mol. Ther. Nucleic Acids. 2021;23:691&#x2013;701. doi: 10.1016/j.omtn.2020.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2020.12.030</ArticleId><ArticleId IdType="pmc">PMC7851496</ArticleId><ArticleId IdType="pubmed">33575115</ArticleId></ArticleIdList></Reference><Reference><Citation>Artusi S., Ruggiero E., Nadai M., Tosoni B., Perrone R., Ferino A., Zanin I., Xodo L., Flamand L., Richter S.N. Antiviral Activity of the G-Quadruplex Ligand TMPyP4 against Herpes Simplex Virus-1. Viruses. 2021;13:196. doi: 10.3390/v13020196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020196</ArticleId><ArticleId IdType="pmc">PMC7911665</ArticleId><ArticleId IdType="pubmed">33525505</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L.W., Qian M.Q., Yu K., Narva S., Yu F., Wu Y.L., Zhang W. Inhibition of Influenza A virus propagation by benzoselenoxanthenes stabilizing TMPRSS2 Gene G-quadruplex and hence down-regulating TMPRSS2 expression. Sci. Rep. 2020;10:7635. doi: 10.1038/s41598-020-64368-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-64368-8</ArticleId><ArticleId IdType="pmc">PMC7203196</ArticleId><ArticleId IdType="pubmed">32376987</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohde G. Drug targets in rhinoviral infections. Infect. Disord. Drug Targets. 2009;9:126&#x2013;132. doi: 10.2174/187152609787847695.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152609787847695</ArticleId><ArticleId IdType="pubmed">19275701</ArticleId></ArticleIdList></Reference><Reference><Citation>Norder H., De Palma A.M., Selisko B., Costenaro L., Papageorgiou N., Arnan C., Coutard B., Lantez V., De Lamballerie X., Baronti C., et al. Picornavirus non-structural proteins as targets for new anti-virals with broad activity. Antivir. Res. 2011;89:204&#x2013;218. doi: 10.1016/j.antiviral.2010.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2010.12.007</ArticleId><ArticleId IdType="pubmed">21236302</ArticleId></ArticleIdList></Reference><Reference><Citation>Denani C.B., Real-Hohn A., de Carvalho C.A.M., Gomes A.M.O., Goncalves R.B. Lactoferrin affects rhinovirus B-14 entry into H1-HeLa cells. Arch. Virol. 2021;166:1203&#x2013;1211. doi: 10.1007/s00705-021-04993-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-04993-4</ArticleId><ArticleId IdType="pmc">PMC7894240</ArticleId><ArticleId IdType="pubmed">33606112</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng T.Y., Chen L.C., Shyu H.W., Chen S.H., Wang J.R., Yu C.K., Lei H.Y., Yeh T.M. Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antivir. Res. 2005;67:31&#x2013;37. doi: 10.1016/j.antiviral.2005.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2005.03.005</ArticleId><ArticleId IdType="pubmed">15916817</ArticleId></ArticleIdList></Reference><Reference><Citation>Seganti L., Di Biase A.M., Marchetti M., Pietrantoni A., Tinari A., Superti F. Antiviral activity of lactoferrin towards naked viruses. Biometals. 2004;17:295&#x2013;299. doi: 10.1023/B:BIOM.0000027708.27142.bc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:BIOM.0000027708.27142.bc</ArticleId><ArticleId IdType="pubmed">15222481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.Y., Chu C., Chiu C.H. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J. Infect. Dis. 2002;186:1161&#x2013;1164. doi: 10.1086/343809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/343809</ArticleId><ArticleId IdType="pubmed">12355368</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti M., Superti F., Ammendolia M.G., Rossi P., Valenti P., Seganti L. Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin. Med. Microbiol. Immunol. 1999;187:199&#x2013;204. doi: 10.1007/s004300050093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004300050093</ArticleId><ArticleId IdType="pubmed">10363676</ArticleId></ArticleIdList></Reference><Reference><Citation>Eccles R., Winther B., Johnston S.L., Robinson P., Trampisch M., Koelsch S. Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: The ICICC trial. Respir. Res. 2015;16:121. doi: 10.1186/s12931-015-0281-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-015-0281-8</ArticleId><ArticleId IdType="pmc">PMC4595062</ArticleId><ArticleId IdType="pubmed">26438038</ArticleId></ArticleIdList></Reference><Reference><Citation>Bichiri D., Rente A.R., Jesus A. Safety and efficacy of iota-carrageenan nasal spray in treatment and prevention of the common cold. Med. Pharm. Rep. 2021;94:28&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7880062</ArticleId><ArticleId IdType="pubmed">33629045</ArticleId></ArticleIdList></Reference><Reference><Citation>Geller R., Vignuzzi M., Andino R., Frydman J. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev. 2007;21:195&#x2013;205. doi: 10.1101/gad.1505307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1505307</ArticleId><ArticleId IdType="pmc">PMC1770902</ArticleId><ArticleId IdType="pubmed">17234885</ArticleId></ArticleIdList></Reference><Reference><Citation>Brabec M., Blaas D., Fuchs R. Wortmannin delays transfer of human rhinovirus serotype 2 to late endocytic compartments. Biochem. Biophys. Res. Commun. 2006;348:741&#x2013;749. doi: 10.1016/j.bbrc.2006.07.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.07.125</ArticleId><ArticleId IdType="pubmed">16890915</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganjian H., Zietz C., Mechtcheriakova D., Blaas D., Fuchs R. ICAM-1 Binding Rhinoviruses Enter HeLa Cells via Multiple Pathways and Travel to Distinct Intracellular Compartments for Uncoating. Viruses. 2017;9:68. doi: 10.3390/v9040068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v9040068</ArticleId><ArticleId IdType="pmc">PMC5408674</ArticleId><ArticleId IdType="pubmed">28368306</ArticleId></ArticleIdList></Reference><Reference><Citation>Albulescu L., Bigay J., Biswas B., Weber-Boyvat M., Dorobantu C.M., Delang L., van der Schaar H.M., Jung Y.S., Neyts J., Olkkonen V.M., et al. Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307. Antivir. Res. 2017;140:37&#x2013;44. doi: 10.1016/j.antiviral.2017.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.01.008</ArticleId><ArticleId IdType="pubmed">28088354</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaas D. Viral entry pathways: The example of common cold viruses. Wien. Med. Wochenschr. 2016;166:211&#x2013;226. doi: 10.1007/s10354-016-0461-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10354-016-0461-2</ArticleId><ArticleId IdType="pmc">PMC4871925</ArticleId><ArticleId IdType="pubmed">27174165</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurgeit A., McDowell R., Moese S., Meldrum E., Schwendener R., Greber U.F. Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects. PLoS Pathog. 2012;8:e1002976. doi: 10.1371/journal.ppat.1002976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002976</ArticleId><ArticleId IdType="pmc">PMC3486884</ArticleId><ArticleId IdType="pubmed">23133371</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T., Yamaya M., Sekizawa K., Hosoda M., Yamada N., Ishizuka S., Nakayama K., Yanai M., Numazaki Y., Sasaki H. Bafilomycin A(1) inhibits rhinovirus infection in human airway epithelium: Effects on endosome and ICAM-1. Am. J. Physiol. Lung Cell Mol. Physiol. 2001;280:L1115&#x2013;L1127. doi: 10.1152/ajplung.2001.280.6.L1115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.2001.280.6.L1115</ArticleId><ArticleId IdType="pubmed">11350790</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfanzagl B., Andergassen D., Edlmayr J., Niespodziana K., Valenta R., Blaas D. Entry of human rhinovirus 89 via ICAM-1 into HeLa epithelial cells is inhibited by actin skeleton disruption and by bafilomycin. Arch. Virol. 2014;159:125&#x2013;140. doi: 10.1007/s00705-013-1797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-013-1797-1</ArticleId><ArticleId IdType="pubmed">23913188</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurani G., Lindqvist B., Casasnovas J.M. Receptor priming of major group human rhinoviruses for uncoating and entry at mild low-pH environments. J. Virol. 2003;77:11985&#x2013;11991. doi: 10.1128/JVI.77.22.11985-11991.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.22.11985-11991.2003</ArticleId><ArticleId IdType="pmc">PMC254263</ArticleId><ArticleId IdType="pubmed">14581535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.R., Song J.H., Ahn J.H., Lee G.S., Ahn H., Yoon S.I., Kang S.G., Kim P.H., Jeon S.M., Choi E.J., et al. Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation. Antivir. Res. 2018;151:87&#x2013;96. doi: 10.1016/j.antiviral.2018.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.01.012</ArticleId><ArticleId IdType="pubmed">29407486</ArticleId></ArticleIdList></Reference><Reference><Citation>Real-Hohn A., Provance D.W., Jr., Goncalves R.B., Denani C.B., de Oliveira A.C., Salerno V.P., Oliveira Gomes A.M. Impairing the function of MLCK, myosin Va or myosin Vb disrupts Rhinovirus B14 replication. Sci. Rep. 2017;7:17153. doi: 10.1038/s41598-017-17501-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17501-z</ArticleId><ArticleId IdType="pmc">PMC5719429</ArticleId><ArticleId IdType="pubmed">29215055</ArticleId></ArticleIdList></Reference><Reference><Citation>Konecsni T., Kremser L., Snyers L., Rankl C., Kilar F., Kenndler E., Blaas D. Twelve receptor molecules attach per viral particle of human rhinovirus serotype 2 via multiple modules. FEBS Lett. 2004;568:99&#x2013;104. doi: 10.1016/j.febslet.2004.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2004.05.015</ArticleId><ArticleId IdType="pubmed">15196928</ArticleId></ArticleIdList></Reference><Reference><Citation>Crump C.E., Arruda E., Hayden F.G. Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A molecule. Antimicrob. Agents Chemother. 1994;38:1425&#x2013;1427. doi: 10.1128/AAC.38.6.1425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.38.6.1425</ArticleId><ArticleId IdType="pmc">PMC188225</ArticleId><ArticleId IdType="pubmed">7916558</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohlin A., Hoover-Litty H., Sanderson G., Paessens A., Johnston S.L., Holgate S.T., Huguenel E., Greve J.M. Spectrum of activity of soluble intercellular adhesion molecule-1 against rhinovirus reference strains and field isolates. Antimicrob. Agents Chemother. 1994;38:1413&#x2013;1415. doi: 10.1128/AAC.38.6.1413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.38.6.1413</ArticleId><ArticleId IdType="pmc">PMC188221</ArticleId><ArticleId IdType="pubmed">7916557</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S., Casanovas J.M., Staunton D.E., Springer T.A. [Successful prevention of rhinovirus infections with chimeric ICAM-1 immunoglobulin in vitro] Med. Klin. 1993;88:193&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">8098506</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivero-Buceta E., Sun L., Martinez-Gualda B., Doyaguez E.G., Donckers K., Quesada E., Camarasa M.J., Delang L., San-Felix A., Neyts J., et al. Optimization of a Class of Tryptophan Dendrimers That Inhibit HIV Replication Leads to a Selective, Specific, and Low-Nanomolar Inhibitor of Clinical Isolates of Enterovirus A71. Antimicrob. Agents Chemother. 2016;60:5064&#x2013;5067. doi: 10.1128/AAC.00626-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00626-16</ArticleId><ArticleId IdType="pmc">PMC4958208</ArticleId><ArticleId IdType="pubmed">27246775</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualdoni G.A., Mayer K.A., Kapsch A.M., Kreuzberg K., Puck A., Kienzl P., Oberndorfer F., Fruhwirth K., Winkler S., Blaas D., et al. Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication. Proc. Natl. Acad. Sci. USA. 2018;115:E7158&#x2013;E7165. doi: 10.1073/pnas.1800525115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800525115</ArticleId><ArticleId IdType="pmc">PMC6065033</ArticleId><ArticleId IdType="pubmed">29987044</ArticleId></ArticleIdList></Reference><Reference><Citation>Gielen V., Johnston S.L., Edwards M.R. Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur. Respir. J. 2010;36:646. doi: 10.1183/09031936.00095809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00095809</ArticleId><ArticleId IdType="pubmed">20150207</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa F.H., Casanova V., Findlay F., Stevens C., Svoboda P., Pohl J., Proudfoot L., Barlow P.G. Cathelicidins display conserved direct antiviral activity towards rhinovirus. Peptides. 2017;95:76&#x2013;83. doi: 10.1016/j.peptides.2017.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.peptides.2017.07.013</ArticleId><ArticleId IdType="pmc">PMC5577862</ArticleId><ArticleId IdType="pubmed">28764966</ArticleId></ArticleIdList></Reference><Reference><Citation>Real-Hohn A., Groznica M., Kontaxis G., Zhu R., Chaves O., Vazquez L., Hinterdorfer P., Blaas D., Kowalski H. Targeting G-quadruplexes in the rhinovirus genome by Pyridostatin inhibits uncoating and highlights a critical role for sodium ions. Res. Square. 2021 doi: 10.21203/rs.3.rs-646190/v2.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-646190/v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlquist P., Kaesberg P. Determination of the length distribution of poly(A) at the 3&#x2032; terminus of the virion RNAs of EMC virus, poliovirus, rhinovirus, RAV-61 and CPMV and of mouse globin mRNA. Nucleic Acids Res. 1979;7:1195&#x2013;1204. doi: 10.1093/nar/7.5.1195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/7.5.1195</ArticleId><ArticleId IdType="pmc">PMC342296</ArticleId><ArticleId IdType="pubmed">229465</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Wang C., Mueller S., Paul A.V., Wimmer E., Jiang P. Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog. 2010;6:e1001066. doi: 10.1371/journal.ppat.1001066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001066</ArticleId><ArticleId IdType="pmc">PMC2928791</ArticleId><ArticleId IdType="pubmed">20865167</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J., Liu Y., Wimmer E., Paul A.V. Complete protein linkage map between the P2 and P3 non-structural proteins of poliovirus. J. Gen. Virol. 2007;88 Pt 8:2259&#x2013;2267. doi: 10.1099/vir.0.82795-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82795-0</ArticleId><ArticleId IdType="pubmed">17622630</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.P., Baltimore D. An intragenic revertant of a poliovirus 2C mutant has an uncoating defect. J. Virol. 1990;64:1102&#x2013;1107. doi: 10.1128/jvi.64.3.1102-1107.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.64.3.1102-1107.1990</ArticleId><ArticleId IdType="pmc">PMC249223</ArticleId><ArticleId IdType="pubmed">2154595</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris J.R., Racaniello V.R. Changes in rhinovirus protein 2C allow efficient replication in mouse cells. J. Virol. 2003;77:4773&#x2013;4780. doi: 10.1128/JVI.77.8.4773-4780.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.8.4773-4780.2003</ArticleId><ArticleId IdType="pmc">PMC152148</ArticleId><ArticleId IdType="pubmed">12663784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.H., Wang K., Zhao K., Hua S.C., Du J. The Structure, Function, and Mechanisms of Action of Enterovirus Non-structural Protein 2C. Front. Microbiol. 2020;11:615965. doi: 10.3389/fmicb.2020.615965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.615965</ArticleId><ArticleId IdType="pmc">PMC7767853</ArticleId><ArticleId IdType="pubmed">33381104</ArticleId></ArticleIdList></Reference><Reference><Citation>Asare E., Mugavero J., Jiang P., Wimmer E., Paul A.V. A Single Amino Acid Substitution in Poliovirus Nonstructural Protein 2CATPase Causes Conditional Defects in Encapsidation and Uncoating. J. Virol. 2016;90:6174&#x2013;6186. doi: 10.1128/JVI.02877-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02877-15</ArticleId><ArticleId IdType="pmc">PMC4936127</ArticleId><ArticleId IdType="pubmed">27076638</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfister T., Pasamontes L., Troxler M., Egger D., Bienz K. Immunocytochemical localization of capsid-related particles in subcellular fractions of poliovirus-infected cells. Virology. 1992;188:676&#x2013;684. doi: 10.1016/0042-6822(92)90522-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(92)90522-Q</ArticleId><ArticleId IdType="pubmed">1316678</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Wang J.C., Taylor M.W., Zlotnick A. In vitro assembly of an empty picornavirus capsid follows a dodecahedral path. J. Virol. 2012;86:13062&#x2013;13069. doi: 10.1128/JVI.01033-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01033-12</ArticleId><ArticleId IdType="pmc">PMC3497625</ArticleId><ArticleId IdType="pubmed">23015694</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson A.J., Hu Y.H., Keinan E. Chemical mimicry of viral capsid self-assembly. Proc. Natl. Acad. Sci. USA. 2007;104:20731&#x2013;20736. doi: 10.1073/pnas.0709489104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0709489104</ArticleId><ArticleId IdType="pmc">PMC2410070</ArticleId><ArticleId IdType="pubmed">18093950</ArticleId></ArticleIdList></Reference><Reference><Citation>Molla A., Paul A.V., Wimmer E. Cell-free, de novo synthesis of poliovirus. Science. 1991;254:1647&#x2013;1651. doi: 10.1126/science.1661029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1661029</ArticleId><ArticleId IdType="pubmed">1661029</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsian J., Fox H., Bahar M.W., Kotecha A., Fry E.E., Stuart D.I., Macadam A.J., Rowlands D.J., Lomonossoff G.P. Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine. Nat. Commun. 2017;8:245. doi: 10.1038/s41467-017-00090-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00090-w</ArticleId><ArticleId IdType="pmc">PMC5557999</ArticleId><ArticleId IdType="pubmed">28811473</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakeel S., Dykeman E.C., White S.J., Ora A., Cockburn J.J.B., Butcher S.J., Stockley P.G., Twarock R. Genomic RNA folding mediates assembly of human parechovirus. Nat. Commun. 2017;8:5. doi: 10.1038/s41467-016-0011-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-016-0011-z</ArticleId><ArticleId IdType="pmc">PMC5431903</ArticleId><ArticleId IdType="pubmed">28232749</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandler-Bostock R., Mata C.P., Bingham R.J., Dykeman E.C., Meng B., Tuthill T.J., Rowlands D.J., Ranson N.A., Twarock R., Stockley P.G. Assembly of infectious enteroviruses depends on multiple, conserved genomic RNA-coat protein contacts. PLoS Pathog. 2020;16:e1009146. doi: 10.1371/journal.ppat.1009146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009146</ArticleId><ArticleId IdType="pmc">PMC7793301</ArticleId><ArticleId IdType="pubmed">33370422</ArticleId></ArticleIdList></Reference><Reference><Citation>Twarock R., Stockley P.G. RNA-Mediated Virus Assembly: Mechanisms and Consequences for Viral Evolution and Therapy. Annu. Rev. Biophys. 2019;48:495&#x2013;514. doi: 10.1146/annurev-biophys-052118-115611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biophys-052118-115611</ArticleId><ArticleId IdType="pmc">PMC7612295</ArticleId><ArticleId IdType="pubmed">30951648</ArticleId></ArticleIdList></Reference><Reference><Citation>Twarock R., Bingham R.J., Dykeman E.C., Stockley P.G. A modelling paradigm for RNA virus assembly. Curr. Opin. Virol. 2018;31:74&#x2013;81. doi: 10.1016/j.coviro.2018.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2018.07.003</ArticleId><ArticleId IdType="pmc">PMC6281560</ArticleId><ArticleId IdType="pubmed">30078702</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel N., Wroblewski E., Leonov G., Phillips S.E.V., Tuma R., Twarock R., Stockley P.G. Rewriting nature&#x2019;s assembly manual for a ssRNA virus. Proc. Natl. Acad. Sci. USA. 2017;114:12255&#x2013;12260. doi: 10.1073/pnas.1706951114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1706951114</ArticleId><ArticleId IdType="pmc">PMC5699041</ArticleId><ArticleId IdType="pubmed">29087310</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaas D. Individual subunits of a rhinovirus causing common cold exhibit largely different protein-RNA contact site conformations. Commun. Biol. 2020;3:537. doi: 10.1038/s42003-020-01269-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-020-01269-6</ArticleId><ArticleId IdType="pmc">PMC7525237</ArticleId><ArticleId IdType="pubmed">32994533</ArticleId></ArticleIdList></Reference><Reference><Citation>Harutyunyan S., Kumar M., Sedivy A., Subirats X., Kowalski H., Kohler G., Blaas D. Viral uncoating is directional: Exit of the genomic RNA in a common cold virus starts with the poly-(A) tail at the 3&#x2032;-end. PLoS Pathog. 2013;9:e1003270. doi: 10.1371/journal.ppat.1003270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003270</ArticleId><ArticleId IdType="pmc">PMC3617019</ArticleId><ArticleId IdType="pubmed">23592991</ArticleId></ArticleIdList></Reference><Reference><Citation>Harutyunyan S., Kowalski H., Blaas D. The Rhinovirus subviral a-particle exposes 3&#x2032;-terminal sequences of its genomic RNA. J. Virol. 2014;88:6307&#x2013;6317. doi: 10.1128/JVI.00539-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00539-14</ArticleId><ArticleId IdType="pmc">PMC4093901</ArticleId><ArticleId IdType="pubmed">24672023</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg A.C., Sgro J.Y. Topological organization of picornaviral genomes: Statistical prediction of RNA structural signals. Semin. Virol. 1997;8:231&#x2013;241. doi: 10.1006/smvy.1997.0126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/smvy.1997.0126</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss M., Levy H.C., Bostina M., Filman D.J., Hogle J.M. RNA transfer from poliovirus 135S particles across membranes is mediated by long umbilical connectors. J. Virol. 2013;87:3903&#x2013;3914. doi: 10.1128/JVI.03209-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03209-12</ArticleId><ArticleId IdType="pmc">PMC3624230</ArticleId><ArticleId IdType="pubmed">23365424</ArticleId></ArticleIdList></Reference><Reference><Citation>Hreb&#xed;k D., F&#xfc;zik T., Gondov&#xe1; M., &#x160;merdov&#xe1; L., Adamopoulos A., &#x160;edo O., Zdr&#xe1;hal Z., Plevka P. ICAM-1 induced rearrangements of capsid and genome prime rhinovirus 14 for activation and uncoating. Proc. Natl. Acad. Sci. USA. 2021;118:e2024251118. doi: 10.1073/pnas.2024251118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024251118</ArticleId><ArticleId IdType="pmc">PMC8126848</ArticleId><ArticleId IdType="pubmed">33947819</ArticleId></ArticleIdList></Reference><Reference><Citation>Real-Hohn A., Groznica M., Loffler N., Blaas D., Kowalski H. nanoDSF: In vitro Label-Free Method to Monitor Picornavirus Uncoating and Test Compounds Affecting Particle Stability. Front. Microbiol. 2020;11:1442. doi: 10.3389/fmicb.2020.01442.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01442</ArticleId><ArticleId IdType="pmc">PMC7333345</ArticleId><ArticleId IdType="pubmed">32676065</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing P., Burris B., Zhang R. Forces from the Portal Govern the Late-Stage DNA Transport in a Viral DNA Packaging Nanomotor. Biophys. J. 2016;111:162&#x2013;177. doi: 10.1016/j.bpj.2016.05.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2016.05.040</ArticleId><ArticleId IdType="pmc">PMC4945582</ArticleId><ArticleId IdType="pubmed">27410744</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal A., Egecioglu D.E., Yoffe A.M., Ben-Shaul A., Rao A.L., Knobler C.M., Gelbart W.M. Viral RNAs are unusually compact. PLoS ONE. 2014;9:e105875. doi: 10.1371/journal.pone.0105875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105875</ArticleId><ArticleId IdType="pmc">PMC4154850</ArticleId><ArticleId IdType="pubmed">25188030</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss N.R., Gerstein M. Calculation of standard atomic volumes for RNA and comparison with proteins: RNA is packed more tightly. J. Mol. Biol. 2005;346:477&#x2013;492. doi: 10.1016/j.jmb.2004.11.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2004.11.072</ArticleId><ArticleId IdType="pubmed">15670598</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuznetsov Y.G., Daijogo S., Zhou J., Semler B.L., McPherson A. Atomic force microscopy analysis of icosahedral virus RNA. J. Mol. Biol. 2005;347:41&#x2013;52. doi: 10.1016/j.jmb.2005.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2005.01.006</ArticleId><ArticleId IdType="pubmed">15733916</ArticleId></ArticleIdList></Reference><Reference><Citation>Madshus I.H., Olsnes S., Sandvig K. Different pH requirements for entry of the two picornaviruses, human rhinovirus 2 and murine encephalomyocarditis virus. Virology. 1984;139:346&#x2013;357. doi: 10.1016/0042-6822(84)90380-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(84)90380-5</ArticleId><ArticleId IdType="pubmed">6097029</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowther D., Melnick J.L. The incorporation of neutral red and acridine orange into developing poliovirus particles making them photosensitive. Virology. 1961;14:11&#x2013;21. doi: 10.1016/0042-6822(61)90127-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(61)90127-1</ArticleId><ArticleId IdType="pubmed">13696675</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandenburg B., Lee L.Y., Lakadamyali M., Rust M.J., Zhuang X., Hogle J.M. Imaging poliovirus entry in live cells. PLoS Biol. 2007;5:e183. doi: 10.1371/journal.pbio.0050183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0050183</ArticleId><ArticleId IdType="pmc">PMC1914398</ArticleId><ArticleId IdType="pubmed">17622193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremser L., Petsch M., Blaas D., Kenndler E. Labeling of capsid proteins and genomic RNA of human rhinovirus with two different fluorescent dyes for selective detection by capillary electrophoresis. Anal. Chem. 2004;76:7360&#x2013;7365. doi: 10.1021/ac048999m.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac048999m</ArticleId><ArticleId IdType="pubmed">15595880</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber R.G., Lim X.N., Ng W.C., Sim A.Y.L., Poh H.X., Shen Y., Lim S.Y., Sundstrom K.B., Sun X., Aw J.G., et al. Structure mapping of dengue and Zika viruses reveals functional long-range interactions. Nat. Commun. 2019;10:1408. doi: 10.1038/s41467-019-09391-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09391-8</ArticleId><ArticleId IdType="pmc">PMC6441010</ArticleId><ArticleId IdType="pubmed">30926818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziv O., Price J., Shalamova L., Kamenova T., Goodfellow I., Weber F., Miska E.A. The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2. Mol. Cell. 2020;80:1067&#x2013;1077.e5. doi: 10.1016/j.molcel.2020.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.11.004</ArticleId><ArticleId IdType="pmc">PMC7643667</ArticleId><ArticleId IdType="pubmed">33259809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Li K., Bai J., Velema W.A., Yu C., van Damme R., Lee W.H., Corpuz M.L., Chen J.F., Lu Z. Optimized photochemistry enables efficient analysis of dynamic RNA structuromes and interactomes in genetic and infectious diseases. Nat. Commun. 2021;12:2344. doi: 10.1038/s41467-021-22552-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22552-y</ArticleId><ArticleId IdType="pmc">PMC8058046</ArticleId><ArticleId IdType="pubmed">33879794</ArticleId></ArticleIdList></Reference><Reference><Citation>Broo K., Wei J., Marshall D., Brown F., Smith T.J., Johnson J.E., Schneemann A., Siuzdak G. Viral capsid mobility: A dynamic conduit for inactivation. Proc. Natl. Acad. Sci. USA. 2001;98:2274&#x2013;2277. doi: 10.1073/pnas.051598298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.051598298</ArticleId><ArticleId IdType="pmc">PMC30128</ArticleId><ArticleId IdType="pubmed">11226229</ArticleId></ArticleIdList></Reference><Reference><Citation>Speir J.A., Johnson J.E. Nucleic acid packaging in viruses. Curr. Opin. Struct. Biol. 2012;22:65&#x2013;71. doi: 10.1016/j.sbi.2011.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2011.11.002</ArticleId><ArticleId IdType="pmc">PMC3288730</ArticleId><ArticleId IdType="pubmed">22277169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha A., Zhang F., Juleff N., Jackson T., Perez E., Stuart D., Fry E., Charleston B., Seago J. Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation. J. Gen. Virol. 2016;97:1557&#x2013;1565. doi: 10.1099/jgv.0.000462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000462</ArticleId><ArticleId IdType="pmc">PMC5042063</ArticleId><ArticleId IdType="pubmed">27002540</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez de Groot N., Armaos A., Grana-Montes R., Alriquet M., Calloni G., Vabulas R.M., Tartaglia G.G. RNA structure drives interaction with proteins. Nat. Commun. 2019;10:3246. doi: 10.1038/s41467-019-10923-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10923-5</ArticleId><ArticleId IdType="pmc">PMC6642211</ArticleId><ArticleId IdType="pubmed">31324771</ArticleId></ArticleIdList></Reference><Reference><Citation>Noller H.F., Hoffarth V., Zimniak L. Unusual resistance of peptidyl transferase to protein extraction procedures. Science. 1992;256:1416&#x2013;1419. doi: 10.1126/science.1604315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1604315</ArticleId><ArticleId IdType="pubmed">1604315</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascal S.M., Garimella R., Warden M.S., Ponniah K. Structural Biology of the Enterovirus Replication-Linked 5&#x2032;-Cloverleaf RNA and Associated Virus Proteins. Microbiol. Mol. Biol. Rev. 2020;84:e00062-19. doi: 10.1128/MMBR.00062-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00062-19</ArticleId><ArticleId IdType="pmc">PMC7399744</ArticleId><ArticleId IdType="pubmed">32188627</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohll J.B., Percy N., Ley R., Evans D.J., Almond J.W., Barclay W.S. The 5&#x2032;-untranslated regions of picornavirus RNAs contain independent functional domains essential for RNA replication and translation. J. Virol. 1994;68:4384&#x2013;4391. doi: 10.1128/jvi.68.7.4384-4391.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.68.7.4384-4391.1994</ArticleId><ArticleId IdType="pmc">PMC236362</ArticleId><ArticleId IdType="pubmed">8207812</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavezzo E., Berselli M., Frasson I., Perrone R., Palu G., Brazzale A.R., Richter S.N., Toppo S. G-quadruplex forming sequences in the genome of all known human viruses: A comprehensive guide. PLoS Comput. Biol. 2018;14:e1006675. doi: 10.1371/journal.pcbi.1006675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1006675</ArticleId><ArticleId IdType="pmc">PMC6307822</ArticleId><ArticleId IdType="pubmed">30543627</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Qin G., Niu J., Wang Z., Wang C., Ren J., Qu X. Targeting RNA G-Quadruplex in SARS-CoV-2: A Promising Therapeutic Target for COVID-19? Angew. Chem. Int. Ed. 2021;60:432&#x2013;438. doi: 10.1002/anie.202011419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202011419</ArticleId><ArticleId IdType="pubmed">32939952</ArticleId></ArticleIdList></Reference><Reference><Citation>Metifiot M., Amrane S., Litvak S., Andreola M.L. G-quadruplexes in viruses: Function and potential therapeutic applications. Nucleic Acids Res. 2014;42:12352&#x2013;12366. doi: 10.1093/nar/gku999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku999</ArticleId><ArticleId IdType="pmc">PMC4227801</ArticleId><ArticleId IdType="pubmed">25332402</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri R., Bhattacharya S., Dash J., Bhattacharya S. Recent Update on Targeting c-MYC G-Quadruplexes by Small Molecules for Anticancer Therapeutics. J. Med. Chem. 2021;64:42&#x2013;70. doi: 10.1021/acs.jmedchem.0c01145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.0c01145</ArticleId><ArticleId IdType="pubmed">33355454</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumas L., Herviou P., Dassi E., Cammas A., Millevoi S. G-Quadruplexes in RNA Biology: Recent Advances and Future Directions. Trends Biochem. Sci. 2021;46:270&#x2013;283. doi: 10.1016/j.tibs.2020.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2020.11.001</ArticleId><ArticleId IdType="pubmed">33303320</ArticleId></ArticleIdList></Reference><Reference><Citation>Banco M.T., Ferre-D&#x2019;Amare A.R. The emerging structural complexity of G-quadruplex RNAs. RNA. 2021;27:390&#x2013;402. doi: 10.1261/rna.078238.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.078238.120</ArticleId><ArticleId IdType="pmc">PMC7962482</ArticleId><ArticleId IdType="pubmed">33483368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggiero E., Richter S.N. G-quadruplexes and G-quadruplex ligands: Targets and tools in antiviral therapy. Nucleic Acids Res. 2018;46:3270&#x2013;3283. doi: 10.1093/nar/gky187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky187</ArticleId><ArticleId IdType="pmc">PMC5909458</ArticleId><ArticleId IdType="pubmed">29554280</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.K., Wu Y., Ou T.M. RNA G-Quadruplex: The New Potential Targets for Therapy. Curr. Top. Med. Chem. 2015;15:1947&#x2013;1956. doi: 10.2174/1568026615666150515145733.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026615666150515145733</ArticleId><ArticleId IdType="pubmed">25980415</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonrich G., Raftery M.J. Neutrophil Extracellular Traps Go Viral. Front. Immunol. 2016;7:366. doi: 10.3389/fimmu.2016.00366.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00366</ArticleId><ArticleId IdType="pmc">PMC5027205</ArticleId><ArticleId IdType="pubmed">27698656</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Gorbatsevych O., Liu Y., Mugavero J., Shen S.H., Ward C.B., Asare E., Jiang P., Paul A.V., Mueller S., et al. Limits of variation, specific infectivity, and genome packaging of massively recoded poliovirus genomes. Proc. Natl. Acad. Sci. USA. 2017;114:E8731&#x2013;E8740. doi: 10.1073/pnas.1714385114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1714385114</ArticleId><ArticleId IdType="pmc">PMC5642728</ArticleId><ArticleId IdType="pubmed">28973853</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman J.R., Papamichail D., Skiena S., Futcher B., Wimmer E., Mueller S. Virus attenuation by genome-scale changes in codon pair bias. Science. 2008;320:1784&#x2013;1787. doi: 10.1126/science.1155761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1155761</ArticleId><ArticleId IdType="pmc">PMC2754401</ArticleId><ArticleId IdType="pubmed">18583614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikin O., D&#x2019;Antonio L., Bagga P.S. QGRS Mapper: A web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res. 2006;34:W676&#x2013;W682. doi: 10.1093/nar/gkl253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl253</ArticleId><ArticleId IdType="pmc">PMC1538864</ArticleId><ArticleId IdType="pubmed">16845096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogloblina A.M., Bannikova V.A., Khristich A.N., Oretskaya T.S., Yakubovskaya M.G., Dolinnaya N.G. Parallel G-Quadruplexes Formed by Guanine-Rich Microsatellite Repeats Inhibit Human Topoisomerase I. Biochemistry. 2015;80:1026&#x2013;1038. doi: 10.1134/S0006297915080088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297915080088</ArticleId><ArticleId IdType="pubmed">26547071</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza A., Cui X., Adrian M., Samazan F., Heddi B., Phan A.T., Nicolas A.G. Non-Canonical G-quadruplexes cause the hCEB1 minisatellite instability in Saccharomyces cerevisiae. eLife. 2017;6:e26884. doi: 10.7554/eLife.26884.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.26884</ArticleId><ArticleId IdType="pmc">PMC5491262</ArticleId><ArticleId IdType="pubmed">28661396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremser L., Okun V.M., Nicodemou A., Blaas D., Kenndler E. Binding of fluorescent dye to genomic RNA inside intact human rhinovirus after viral capsid penetration investigated by capillary electrophoresis. Anal. Chem. 2004;76:882&#x2013;887. doi: 10.1021/ac034898x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac034898x</ArticleId><ArticleId IdType="pubmed">14961716</ArticleId></ArticleIdList></Reference><Reference><Citation>Draper D.E. A guide to ions and RNA structure. RNA. 2004;10:335&#x2013;343. doi: 10.1261/rna.5205404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.5205404</ArticleId><ArticleId IdType="pmc">PMC1370927</ArticleId><ArticleId IdType="pubmed">14970378</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya D., Mirihana Arachchilage G., Basu S. Metal Cations in G-Quadruplex Folding and Stability. Front. Chem. 2016;4:38. doi: 10.3389/fchem.2016.00038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2016.00038</ArticleId><ArticleId IdType="pmc">PMC5016522</ArticleId><ArticleId IdType="pubmed">27668212</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Wei Y., Mei M., Tang L., Sun L., Huang W., Zhou J., Zou C., Zhang S., Qin C.F., et al. Integrative Analysis of Zika Virus Genome RNA Structure Reveals Critical Determinants of Viral Infectivity. Cell Host Microbe. 2018;24:875&#x2013;886.e5. doi: 10.1016/j.chom.2018.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.10.011</ArticleId><ArticleId IdType="pubmed">30472207</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth M., Pettitt T., Symonds A., Martin J. Identification of the pocket factors in a picornavirus. Arch. Virol. 2003;148:1225&#x2013;1233. doi: 10.1007/s00705-002-0974-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-002-0974-4</ArticleId><ArticleId IdType="pubmed">12756627</ArticleId></ArticleIdList></Reference><Reference><Citation>Palika A., Armanious A., Rahimi A., Medaglia C., Gasbarri M., Handschin S., Rossi A., Pohl M.O., Busnadiego I., Gubeli C., et al. An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles. Nat. Nanotechnol. 2021;16:1&#x2013;8. doi: 10.1038/s41565-021-00920-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41565-021-00920-5</ArticleId><ArticleId IdType="pubmed">34083772</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf C., Bernkop-Schnurch A., Egyed A., Koller C., Prieschl-Grassauer E., Morokutti-Kurz M. Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis. Int. J. Gen. Med. 2018;11:275&#x2013;283. doi: 10.2147/IJGM.S167123.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S167123</ArticleId><ArticleId IdType="pmc">PMC6037157</ArticleId><ArticleId IdType="pubmed">30013382</ArticleId></ArticleIdList></Reference><Reference><Citation>Neubauer C., Frasel L., Kuechler E., Blaas D. Mechanism of entry of human rhinovirus 2 into HeLa cells. Virology. 1987;158:255&#x2013;258. doi: 10.1016/0042-6822(87)90264-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(87)90264-9</ArticleId><ArticleId IdType="pubmed">3033893</ArticleId></ArticleIdList></Reference><Reference><Citation>Berei J., Eckburg A., Miliavski E., Anderson A.D., Miller R.J., Dein J., Giuffre A.M., Tang D., Deb S., Racherla K.S., et al. Potential Telomere-Related Pharmacological Targets. Curr. Top. Med. Chem. 2020;20:458&#x2013;484. doi: 10.2174/1568026620666200109114339.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026620666200109114339</ArticleId><ArticleId IdType="pubmed">31916516</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosiol N., Juranek S., Brossart P., Heine A., Paeschke K. G-quadruplexes: A promising target for cancer therapy. Mol. Cancer. 2021;20:40. doi: 10.1186/s12943-021-01328-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-021-01328-4</ArticleId><ArticleId IdType="pmc">PMC7905668</ArticleId><ArticleId IdType="pubmed">33632214</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerofolini L., Amato J., Giachetti A., Limongelli V., Novellino E., Parrinello M., Fragai M., Randazzo A., Luchinat C. G-triplex structure and formation propensity. Nucleic Acids Res. 2014;42:13393&#x2013;13404. doi: 10.1093/nar/gku1084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1084</ArticleId><ArticleId IdType="pmc">PMC4245950</ArticleId><ArticleId IdType="pubmed">25378342</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnat L., Dautriche M., Saidi T., Revol-Cavalier J., Dejeu J., Defrancq E., Lavergne T. Scaffold stabilization of a G-triplex and study of its interactions with G-quadruplex targeting ligands. Org. Biomol. Chem. 2019;17:8726&#x2013;8736. doi: 10.1039/C9OB01537J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9OB01537J</ArticleId><ArticleId IdType="pubmed">31549116</ArticleId></ArticleIdList></Reference><Reference><Citation>Shyr Z.A., Cheng Y.S., Lo D.C., Zheng W. Drug combination therapy for emerging viral diseases. Drug Discov. Today. 2021 doi: 10.1016/j.drudis.2021.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2021.05.008</ArticleId><ArticleId IdType="pmc">PMC8139175</ArticleId><ArticleId IdType="pubmed">34023496</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>